isoproterenol has been researched along with olprinone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endoh, M; Satoh, H | 1 |
| Kuroki, J; Ogawa, T; Ohhara, H; Shoji, T; Tsunoda, H | 1 |
| Enomoto, K; Honda, M; Ishinaga, Y; Kuramochi, T; Kuzuo, H; Morioka, S; Takabatake, T; Tanaka, K | 1 |
| Holubarsch, C | 1 |
| Hamada, H; Kawamoto, M; Kurokawa, H; Matsunaga, A; Tanaka, H; Yuge, O | 1 |
5 other study(ies) available for isoproterenol and olprinone
| Article | Year |
|---|---|
Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Topics: Amrinone; Animals; Bupranolol; Carbachol; Cardiotonic Agents; Cyclic AMP; Dogs; Female; Heart; Heart Ventricles; Imidazoles; In Vitro Techniques; Isometric Contraction; Isoproterenol; Male; Muscle Relaxation; Myocardial Contraction; Myocardium; Pyridones | 1990 |
Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
Topics: Adrenergic beta-Antagonists; Animals; Carbachol; Cardiotonic Agents; Cyclic AMP; Guinea Pigs; Heart; Heart Rate; Hemodynamics; Histamine H2 Antagonists; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Papillary Muscles; Phosphoric Diester Hydrolases; Pyridones; Sodium-Potassium-Exchanging ATPase | 1989 |
Contrasting effects of isoproterenol and phosphodiesterase III inhibitor on intracellular calcium transients in cardiac myocytes from failing hearts.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Fura-2; Heart; Heart Failure; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Monocrotaline; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Sprague-Dawley | 1994 |
New inotropic concepts: rationale for and differences between calcium sensitizers and phosphodiesterase inhibitors.
Topics: Animals; Calcium; Cardiotonic Agents; Deoxyepinephrine; Energy Metabolism; Guinea Pigs; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinolines; Thiadiazines | 1997 |
Clinically relevant concentrations of olprinone reverse attenuating effect of propofol on isoproterenol-induced cyclic adenosine monophosphate accumulation in cardiomyocytes.
Topics: Adrenergic beta-Agonists; Anesthetics, Intravenous; Animals; Cyclic AMP; Dose-Response Relationship, Drug; Imidazoles; Isoproterenol; Male; Myocytes, Cardiac; Phosphodiesterase Inhibitors; Propofol; Pyridones; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta | 2008 |